Determinants of New-Onset Diabetes Among 19,257 Hypertensive Patients Randomized in the Anglo-Scandinavian Cardiac Outcomes Trial–Blood Pressure Lowering Arm and the Relative Influence of Antihypertensive Medication

Gupta, Ajay K., Dahlof, Bjorn, Dobson, Joanna, Sever, Peter S., Wedel, Hans, Poulter, N.R., on behalf of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Investigators·2008·Diabetes Care
DOI 10.2337/dc07-1768

Cited by (146)

Items 101–146 of 146

  1. Diversity in the risk of type 2 diabetes associated with age, sex, and 1-h post-load plasma glucose levels in the Japanese population with prediabetes
    Nobuo Sasaki, Ryo Maeda, Ryoji Ozono, Yukiko Nakano, Yukihito Higashi · 2021 · Diabetes Research and Clinical Practice
  2. Treatment with angiotensin-converting enzyme inhibitors: insight into perindopril cardiovascular protection
    Roberto Ferrari · 2008 · European Heart Journal Supplements
  3. Prioritising Risk Factors for Type 2 Diabetes: Causal Inference through Genetic Approaches
    Laura B. L. Wittemans, Luca Andrea Lotta, Claudia Langenberg · 2018 · Current Diabetes Reports
  4. Body Mass Index and the Risk of Hypertension-Diabetes Comorbidity in Elderly Population: A Prospective Cohort in China
    Haimeng Zhang, Guang-Ling Li, Fan Li, Jian-Gang Jiang · 2025 · Global Heart
  5. The association between sociodemographic characteristics, clinical indicators and body mass index in a population at risk of type 2 diabetes: A cross-sectional study in two Colombian cities
    Yenifer Diaz Montes, Tania Acosta, Rafael Tuesca Molina, Guadalupe Guerrero, Luis A. Anillo Arrieta, Pablo J. Aschner, Jorge Acosta-Reyes, Victor Flórez‐García, Edgar Navarro Lechuga, Noël Christopher Barengo · 2024 · Primary care diabetes
  6. Reducing the Risk of Developing Diabetes: The Role of Angiotensin Receptor Blockers and Angiotensin Converting Enzyme Inhibitors in Patients With Hypertension Combined Prediabetes
    Chenyu Yang, Zhiping Hu, Rina Sa, Rongjing Li, Yi Li, Youwei Wu, Guoshuai Shi, Lin Qiu, Chao Li · 2025 · Journal of Clinical Hypertension
  7. Benefits of perindopril all along the cardiovascular continuum: the level of evidence
    Keith Fox · 2008 · European Heart Journal Supplements
  8. Cardiovascular Toxicity of Cardiovascular Drugs
    Ramachandran Meenakshisundaram, Douglas Ewan Cannie, P Ravi Shankar, Heidar Z. Zadeh, Omi Bajracharya, Ponniah Thirumalaikolundusubramanian · 2014 · Elsevier eBooks
  9. Antihypertensive treatment in diabetic patients. Review of current data
    Georgia Argyrakopoulou, Costas P. Tsioufis, Eleni Sdraka, Dimitris Tsiachris, Konstantinos Makrilakis, Christodoulos Stefanadis · 2013 · Maturitas
  10. Hypertension in Ireland: public awareness and doctors choice of therapy
    Nur Lisa Zaharan, Azra Mahmud, Kathleen Bennett, John Feely · 2009 · Irish Journal of Medical Science (1971 -)
  11. Comparison of real-world effectiveness between valsartan and non-RAS inhibitor monotherapy on the incidence of new diabetes in Chinese hypertensive patients: An electronic health recording system based study
    Shen Tian, Jiwei Wang, Yingjun Yu, Jinming Yu · 2018 · Clinical and Experimental Hypertension
  12. Elevated blood pressure predicts type 2 diabetes, but why?
    Peter M. Nilsson · 2008 · Journal of Hypertension
  13. Evidence-based approach for managing hypertension in type 2 diabetes
    Robert Gabbay · 2010 · Integrated Blood Pressure Control
  14. Casual serum triglyceride as a predictor of premature type 2 diabetes mellitus: an 8-year cohort study of middle-aged Japanese workers
    T Nishikawa, Tomonori Okamura, Azusa Shima, Yuichiro Kawatsu, Daisuke Sugiyama, Aya Kadota, Akira Morimoto, Yukako Tatsumi, Kayo Godai, Naomi Miyamatsu · 2015 · Diabetology International
  15. Lifestyle Intervention: Prevention of Complications to the Metabolic Syndrome
    Pirjo Ilanne‐Parikka, Jaakko O. Tuomilehto · 2013 · Springer eBooks
  16. Disentangling the Causal Association of Plasma Lipid Traits and Type 2 Diabetes Using Human Genetics
    Danish Saleheen, Daniel James Rader, Benjamin F. Voight · 2016 · JAMA Cardiology
  17. Hypertension in metabolic syndrome
    Zhanna D. Kobalava, А. О. Конради, Sergey Vladimirovich Nedogoda · 2025 · Russian Journal of Cardiology
  18. Blood Pressure Control Among Diabetic Patients in the Eastern Mediterranean Region: A Systematic Review and Meta-Analysis
    Amir Hossein Behnoush, Sepehr Khosravi, Fateme Ziamanesh, Rasha Atlasi, Ali Sheidaei, Negin Sanadgol, Amirmohammad Khalaji, Ozra Tabatabaei‐Malazy, Afshin Ostovar · 2024 · Current Diabetes Reviews
  19. Epidemiology and Clinical Features of Arterial Hypertension in Patients with Type 2 Diabetes Mellitus. Literature Review
    Г. А. Игнатенко, Andrey E. Bagriy, Приколота Алина Вадимовна, О. А. Приколота, E. S. Mykhailichenko, И. А. Аршавская, Kristina E. Mogilevskaya · 2024 · The Russian Archives of Internal Medicine
  20. Antihypertensive pharmacogenetics: missed opportunity
    Sandosh Padmanabhan · 2010 · Journal of Hypertension
  21. The effect of antihypertensive agents in people at high risk of cardiovascular disease and diabetes: a view through smoke and mirrors
    Gordon T. McInnes · 2011 · Journal of Human Hypertension
  22. Lack of interaction of beta-cell-function-associated variants with hypertension on change in fasting glucose and diabetes risk
    José María de Miguel-Yanes, Bianca Porneala, Michael J. Pencina, Caroline S. Fox, José C. Florez, David S. Siscovick, Josée Dupuis, James B. Meigs · 2013 · Journal of Hypertension
  23. Which patients would benefit the most from the perindopril-amlodipine combination?
    Nicolas Danchin · 2008 · European Heart Journal Supplements
  24. Understanding the Molecular Crosstalk in Biological Processes
    Mohamed Ahmed El-Esawi · 2019 · IntechOpen eBooks
  25. Biology of Aging and Implications for Heart Failure Therapy and Prevention
    Bodh I. Jugdutt · 2014 · Springer eBooks
  26. Introduction of Recent Hypertension Guidelines
    Hae‐Young Lee · 2014 · Korean Journal of Medicine
  27. A post hoc analysis of saxagliptin efficacy and safety in patients with type 2 diabetes stratified by UKPDS 10-year cardiovascular risk score
    Enzo Bonora, Brian S. Bryzinski, Boaz Hirshberg, W. Cook · 2015 · Nutrition Metabolism and Cardiovascular Diseases
  28. A protocol for an economic evaluation of a polypill in patients with established or at high risk of cardiovascular disease in a UK NHS setting: RUPEE (NHS) study
    Catriona Crossan, Hakim‐Moulay Dehbi, Hilarie Williams, Neil R Poulter, Anthony Rodgers, Stephen Jan, Simon Thom, Joanne L. Lord · 2018 · BMJ Open
  29. Obesity
    Lewis Landsberg · 2017 · Elsevier eBooks
  30. Therapy and clinical trials: metabolic syndrome and cardiovascular risk management
    Mahamood Edavalath, Alan Rees · 2008 · Current Opinion in Lipidology
  31. Prevention of Type 2 Diabetes Mellitus to Reduce Cardiovascular Morbidity and Mortality: A Review of the Evidence
    Thomas D. Giles · 2009 · Journal of Clinical Hypertension
  32. European Society of Hypertension American Society of Nephrology, Association of Black Cardiologists, and Society for Preventive Cardiology, American Society of Hypertension, American Academy of Neurology, American Geriatrics Society, American Developed in Collaboration With the Clinical Expert Consensus Documents A Report of the American College of Cardiology Foundation Task Force on ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly:
    Deborah J. Wesley, Eduardo Ortíz, Efrain Reisin, Michael W. Rich, Douglas D. Schocken, Michael A. Frishman, Cheryl S. Jaigobin, John B. Kostis, Giuseppi Mancia, Suzanne Oparil et al. · 2011
  33. Up-Regulation of Renin-Angiotensin System in Diabetes and Hypertension: Implications on the Development of Diabetic Nephropathy
    Dulce Elena Casarini, Danielle Yuri Arita, Tatiana Sousa, Fernanda Aparecida, Danielle Sanches Aragão, Rodolfo Mattar Rosa, Nadia Sousa Cunha Bertoncello, Fernanda Klein · 2012 · InTech eBooks
  34. Antihypertensive Therapy and New-Onset Diabetes
    Ivana Lazich, George L. Bakris · 2012 · Humana Press eBooks
  35. 4B.04
    E. Chowdhury, Zanfina Ademi, John Robert Moss, L. Wing, Christopher Michael Reid · 2015 · Journal of Hypertension
  36. Selecting a fixed combination to improve morbidity/mortality: the weight of evidence with ASCOT
    Neil R Poulter · 2008 · European Heart Journal Supplements
  37. The relationship of high-density lipoprotein cholesterol to new-onset diabetes: a review
    Roderick Corro Deaño, Henry Tran, Peter M. Okin · 2014 · Diabetes Management
  38. INNOVATIVE ANTIHYPERTENSIVE THERAPY IN THE LIGHT OF COMPLETED CLINICAL TRIALS
    Н. А. Николаев · 2009 · Rational Pharmacotherapy in Cardiology
  39. Статины и риск развития сахарного диабета
    Russian Federation · 2012
  40. Antihypertensive Therapy and New On-set of Diabetes Mellitus: The Double-Edge Sword
    Reza Tabrizchi · 2017 · Journal of Cardiovascular Pharmacology
  41. Comparison Therapies in the Treatment of Hypertension. The ASCOT and ACCOMPLISH Trial
    Nikolaos Magkas, Athanasia I. Kapota, Costas P. Tsioufis · 2018 · Springer eBooks
  42. Hypertension in type 2 diabetes mellitus
    Norman M. Kaplan · 2009 · Dialnet (Universidad de la Rioja)
  43. Current literature in diabetes
    2008 · Diabetes/Metabolism Research and Reviews
  44. Controlling blood pressure and progression of hypertension-dependent cardiovascular continuum by amlodipine and perindopril A single pill fixed‑dose combination: focus on endothelial dysfunction and metabolic risks
    Т. С. Свеклина, Alexey N. Kuchmin, Vladislav V. Konyaev, Октысюк Полина Дмитриевна, A. I. Rechkalova · 2024 · Arterial’naya Gipertenziya (Arterial Hypertension)
  45. Additional file 1 of Association between high-density lipoprotein cholesterol and type 2 diabetes mellitus among Chinese: the Beijing longitudinal study of aging
    Cao, Xue, Tang, Zhe, Zhang, Jie, Li, Haibin, Singh, Manjot, Sun, Fei, Li, Xiaochun, Li, Changwei, Wang, Youxin, Guo, Xiuhua et al. · 2021 · Figshare
  46. Carbohydrate metabolism and transformation of pre-diabetes into type 2 diabetes mellitus depending on diagnostic methods in nondiabetic patients with hypertension and high cardiovascular risk
    Veronika V. Tolkacheva, Виллевальде Светлана Вадимовна, Zhanna D. Kobalava · 2012 · Arterial’naya Gipertenziya (Arterial Hypertension)